Mohammad Ullah Nayan on Muck Rack

Mohammad Ullah Nayan

As seen in: MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mohammad Ullah

Contact Mohammad Ullah, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Polymer Delivery Systems for Long-Acting Antiretroviral Drugs

|
By Mohammad Ullah Nayan, Sudipta Panja, Lubaba Zaman, Lalitkumar K. Vora
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared View Duplicates (94) Issue with article?

Polymer Delivery Systems for Long-Acting Antiretroviral Drugs

|
By Mohammad Ullah Nayan, Sudipta Panja, Lubaba Zaman, Lalitkumar K. Vora
| preprints.org
Preprint Review Version 1 This version is not peer-reviewed Version 1 : Received: 20 January 2024 / Approved: 21 January 2024 / Online: 22 January 2024 (04:34:22 CET) Nayan, M.U.; Panja, S.; Sultana, A.; Zaman, L.A.; Vora, L.K.; Sillman, B.J.; Gendelman, H.E.; Edagwa, B. Polymer Delivery Systems for Long-Acting Antiretroviral Drugs. Preprints 2024, 2024011535.
Open in Who Shared Issue with article?

Chronic Hepatitis B Infection: New Approaches towards Cure

|
By Mojisola Ogunnaike, Srijanee Das, Samiksha S. Raut, Mohammad Ullah Nayan
| MDPI
1. Introduction Hepatitis B virus (HBV) in the human population has existed for 2000–3000 years [1], and the chronic disease affects ~300 million (~4%) people [2,3]. Hepatitis B remains a significant public health issue. It is a leading cause of liver-related deaths worldwide. According to the 2019 World Health Organization (WHO) report, hepatitis B resulted in an estimated 820,000 deaths, mostly from cirrhosis and hepatocellular carcinoma (HCC, primary liver cancer).
Open in Who Shared Issue with article?
See all 3 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Mohammad Ullah

Contact Mohammad Ullah, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified